Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers

Bibliographic Details
Main Author: Nau,Angélica Luciana
Publication Date: 2014
Other Authors: Soares,Júlia Cristina, Shiozawa,Maria Beatriz Cacese, Dantas-Corrêa,Esther Buzaglo, Schiavon,Leonardo de Lucca, Narciso-Schiavon,Janaína Luz
Format: Article
Language: eng
Source: Revista da Sociedade Brasileira de Medicina Tropical
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822014000200158
Summary: Introduction Chronic hepatitis B virus (HBV) infection and liver steatosis (LS) are the most common causes of chronic liver disease, and their coexistence is frequently observed in clinical practice. Although metabolic syndrome is the main cause of LS, it has not been associated with HBV infection. The aims of this study were to describe the lipid profile and prevalence of LS among HBV carriers and to identify the characteristics associated with LS in this group. Methods This retrospective cross-sectional study included hepatitis B surface antigen (HBsAg)-positive patients evaluated during 2011 and 2012. Results Of the 83 patients included, the mean age was 46.4±12.5 years, 53% were men, and 9.1% were hepatitis B e antigen (HBeAg) -positive. These patients exhibited the following lipid profile: total cholesterol = 175.4±38.8mg/dL, low-density lipoprotein (LDL) = 113.0±32.7mg/dL, and triglycerides = 91.1±45.2mg/dL. Their fasting glucose was 95.3±14.5g/dL, and fasting insulin was 6.1±5.9µIU/mL. Liver steatosis was observed on abdominal ultrasound in 11.3% of individuals. Factors associated with the presence of LS included higher levels of total cholesterol, prothrombin activity, fasting insulin, and body mass index (BMI) as well as lower levels of aspartate aminotransferase (AST). Conclusions These findings suggest that LS in patients with chronic HBV appears to be a consequence of metabolic alterations and insulin action rather than of viral factors.
id SBMT-1_c0585971599f5d534f377e6661326cfa
oai_identifier_str oai:scielo:S0037-86822014000200158
network_acronym_str SBMT-1
network_name_str Revista da Sociedade Brasileira de Medicina Tropical
repository_id_str
spelling Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriersHBVHepatitis BFatty liverLipidsCholesterolTriglycerides Introduction Chronic hepatitis B virus (HBV) infection and liver steatosis (LS) are the most common causes of chronic liver disease, and their coexistence is frequently observed in clinical practice. Although metabolic syndrome is the main cause of LS, it has not been associated with HBV infection. The aims of this study were to describe the lipid profile and prevalence of LS among HBV carriers and to identify the characteristics associated with LS in this group. Methods This retrospective cross-sectional study included hepatitis B surface antigen (HBsAg)-positive patients evaluated during 2011 and 2012. Results Of the 83 patients included, the mean age was 46.4±12.5 years, 53% were men, and 9.1% were hepatitis B e antigen (HBeAg) -positive. These patients exhibited the following lipid profile: total cholesterol = 175.4±38.8mg/dL, low-density lipoprotein (LDL) = 113.0±32.7mg/dL, and triglycerides = 91.1±45.2mg/dL. Their fasting glucose was 95.3±14.5g/dL, and fasting insulin was 6.1±5.9µIU/mL. Liver steatosis was observed on abdominal ultrasound in 11.3% of individuals. Factors associated with the presence of LS included higher levels of total cholesterol, prothrombin activity, fasting insulin, and body mass index (BMI) as well as lower levels of aspartate aminotransferase (AST). Conclusions These findings suggest that LS in patients with chronic HBV appears to be a consequence of metabolic alterations and insulin action rather than of viral factors. Sociedade Brasileira de Medicina Tropical - SBMT2014-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822014000200158Revista da Sociedade Brasileira de Medicina Tropical v.47 n.2 2014reponame:Revista da Sociedade Brasileira de Medicina Tropicalinstname:Sociedade Brasileira de Medicina Tropical (SBMT)instacron:SBMT10.1590/0037-8682-0009-2014info:eu-repo/semantics/openAccessNau,Angélica LucianaSoares,Júlia CristinaShiozawa,Maria Beatriz CaceseDantas-Corrêa,Esther BuzagloSchiavon,Leonardo de LuccaNarciso-Schiavon,Janaína Luzeng2014-05-15T00:00:00Zoai:scielo:S0037-86822014000200158Revistahttps://www.sbmt.org.br/portal/revista/ONGhttps://old.scielo.br/oai/scielo-oai.php||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br1678-98490037-8682opendoar:2014-05-15T00:00Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)false
dc.title.none.fl_str_mv Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers
title Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers
spellingShingle Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers
Nau,Angélica Luciana
HBV
Hepatitis B
Fatty liver
Lipids
Cholesterol
Triglycerides
title_short Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers
title_full Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers
title_fullStr Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers
title_full_unstemmed Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers
title_sort Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers
author Nau,Angélica Luciana
author_facet Nau,Angélica Luciana
Soares,Júlia Cristina
Shiozawa,Maria Beatriz Cacese
Dantas-Corrêa,Esther Buzaglo
Schiavon,Leonardo de Lucca
Narciso-Schiavon,Janaína Luz
author_role author
author2 Soares,Júlia Cristina
Shiozawa,Maria Beatriz Cacese
Dantas-Corrêa,Esther Buzaglo
Schiavon,Leonardo de Lucca
Narciso-Schiavon,Janaína Luz
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Nau,Angélica Luciana
Soares,Júlia Cristina
Shiozawa,Maria Beatriz Cacese
Dantas-Corrêa,Esther Buzaglo
Schiavon,Leonardo de Lucca
Narciso-Schiavon,Janaína Luz
dc.subject.por.fl_str_mv HBV
Hepatitis B
Fatty liver
Lipids
Cholesterol
Triglycerides
topic HBV
Hepatitis B
Fatty liver
Lipids
Cholesterol
Triglycerides
description Introduction Chronic hepatitis B virus (HBV) infection and liver steatosis (LS) are the most common causes of chronic liver disease, and their coexistence is frequently observed in clinical practice. Although metabolic syndrome is the main cause of LS, it has not been associated with HBV infection. The aims of this study were to describe the lipid profile and prevalence of LS among HBV carriers and to identify the characteristics associated with LS in this group. Methods This retrospective cross-sectional study included hepatitis B surface antigen (HBsAg)-positive patients evaluated during 2011 and 2012. Results Of the 83 patients included, the mean age was 46.4±12.5 years, 53% were men, and 9.1% were hepatitis B e antigen (HBeAg) -positive. These patients exhibited the following lipid profile: total cholesterol = 175.4±38.8mg/dL, low-density lipoprotein (LDL) = 113.0±32.7mg/dL, and triglycerides = 91.1±45.2mg/dL. Their fasting glucose was 95.3±14.5g/dL, and fasting insulin was 6.1±5.9µIU/mL. Liver steatosis was observed on abdominal ultrasound in 11.3% of individuals. Factors associated with the presence of LS included higher levels of total cholesterol, prothrombin activity, fasting insulin, and body mass index (BMI) as well as lower levels of aspartate aminotransferase (AST). Conclusions These findings suggest that LS in patients with chronic HBV appears to be a consequence of metabolic alterations and insulin action rather than of viral factors.
publishDate 2014
dc.date.none.fl_str_mv 2014-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822014000200158
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822014000200158
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0037-8682-0009-2014
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Medicina Tropical - SBMT
publisher.none.fl_str_mv Sociedade Brasileira de Medicina Tropical - SBMT
dc.source.none.fl_str_mv Revista da Sociedade Brasileira de Medicina Tropical v.47 n.2 2014
reponame:Revista da Sociedade Brasileira de Medicina Tropical
instname:Sociedade Brasileira de Medicina Tropical (SBMT)
instacron:SBMT
instname_str Sociedade Brasileira de Medicina Tropical (SBMT)
instacron_str SBMT
institution SBMT
reponame_str Revista da Sociedade Brasileira de Medicina Tropical
collection Revista da Sociedade Brasileira de Medicina Tropical
repository.name.fl_str_mv Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)
repository.mail.fl_str_mv ||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br
_version_ 1752122159190245376